# A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma

> **NCT06564272** · PHASE2 · RECRUITING · sponsor: **Beijing Konruns Pharmaceutical Co., Ltd.** · enrollment: 30 (estimated)

## Conditions studied

- Ewing Sarcoma

## Interventions

- **DRUG:** KC1036

## Key facts

- **NCT ID:** NCT06564272
- **Lead sponsor:** Beijing Konruns Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-27
- **Primary completion:** 2027-04-01
- **Final completion:** 2028-04-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06564272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06564272, "A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT06564272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*